You are here
An evaluation of the safety and efficacy of a hydro soluble nail lacquer (Genadur®) for the treatment of simple brittle nails.
Clinical Trial Details
This study is investigating the affects of a prescription nail lacquer, Genadur®, on brittle nails. The nail lacquer contains natural substances and essential minerals that help protect the nails from losing moisture and damage from day‐to-day friction and trauma.
The treatment consists of a nightly application of the prescription nail lacquer to affected nails on one hand for 16 weeks with 3 doctor visits, with a 4-week follow up visit.
The study lasts approximately 20 weeks, including a screening visit, two visits 8 weeks apart, a 4 week follow up visit.
Patients will be compensated $100 for travel expenses and time.
Key Eligibility:
- Male or Female between the ages of 18-75
- Have signs of Brittle nail syndrome (peeling/splitting of nails) of at least one finger nail(s) on EACH hands
- Willing to give written informed consent and able to adhere to procedures, including a nail clipping to rule out concurrent nail fungus, and visit schedules
- Are not currently undergoing any treatment for their brittle nail syndrome, including over-the-counter vitamins or lacquers.
- Women of childbearing age must meet all the criteria above and agree to a pregnancy test
Study contact by location
Upper East Side - Manhattan
Primary Investigator(s)
Shari Lipner, MD, PhD (UES)
Protocol ID(s)
Weill Cornell Medicine IRB #:
1410015533
Status
Open to Enrollment
Age Group
Adult